Namani et al. applied a 17-gene NRF2 signature to four independent HNSCC datasets and revealed significantly worse OS in the NRF2-active cohorts compared to the control cohort [53]. The gene discussed is NFE2L2; the disease is head and neck squamous cell carcinoma.